CINECA IRIS Institutional Research Information System

MOTTA, ILARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.323
EU - Europa 1.355
AS - Asia 930
SA - Sud America 133
AF - Africa 113
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 7
Totale 4.887
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.229
CN - Cina 355
IT - Italia 312
SE - Svezia 138
SG - Singapore 115
FR - Francia 111
DK - Danimarca 110
IN - India 100
GB - Regno Unito 91
IE - Irlanda 88
DE - Germania 84
ID - Indonesia 83
BR - Brasile 70
ES - Italia 68
AT - Austria 64
FI - Finlandia 53
KR - Corea 49
ZA - Sudafrica 47
CA - Canada 44
MX - Messico 39
VN - Vietnam 39
JP - Giappone 36
PL - Polonia 36
NL - Olanda 35
RU - Federazione Russa 30
TH - Thailandia 30
RO - Romania 29
PK - Pakistan 24
AU - Australia 22
BE - Belgio 21
PE - Perù 21
CO - Colombia 18
TR - Turchia 17
UA - Ucraina 17
AR - Argentina 15
TW - Taiwan 15
CH - Svizzera 14
HK - Hong Kong 12
IR - Iran 12
PH - Filippine 12
HU - Ungheria 10
SK - Slovacchia (Repubblica Slovacca) 10
ML - Mali 9
SN - Senegal 9
CZ - Repubblica Ceca 7
GM - Gambi 7
PT - Portogallo 7
EU - Europa 6
MY - Malesia 6
UG - Uganda 6
EG - Egitto 5
KE - Kenya 5
NO - Norvegia 5
AE - Emirati Arabi Uniti 4
ET - Etiopia 4
JO - Giordania 4
NZ - Nuova Zelanda 4
TN - Tunisia 4
BH - Bahrain 3
CL - Cile 3
EC - Ecuador 3
HN - Honduras 3
IL - Israele 3
LV - Lettonia 3
BG - Bulgaria 2
BO - Bolivia 2
BT - Bhutan 2
BY - Bielorussia 2
CY - Cipro 2
DO - Repubblica Dominicana 2
GE - Georgia 2
GH - Ghana 2
GR - Grecia 2
GT - Guatemala 2
HR - Croazia 2
IQ - Iraq 2
LU - Lussemburgo 2
MA - Marocco 2
PA - Panama 2
SD - Sudan 2
TZ - Tanzania 2
AP - ???statistics.table.value.countryCode.AP??? 1
CF - Repubblica Centrafricana 1
CR - Costa Rica 1
DZ - Algeria 1
EE - Estonia 1
GF - Guiana Francese 1
GN - Guinea 1
KZ - Kazakistan 1
LS - Lesotho 1
LY - Libia 1
MD - Moldavia 1
MO - Macao, regione amministrativa speciale della Cina 1
MW - Malawi 1
NA - Namibia 1
NG - Nigeria 1
QA - Qatar 1
SV - El Salvador 1
TG - Togo 1
Totale 4.887
Salva come PNG Salva come JPEG
Città #
Ann Arbor 308
Chandler 212
Beijing 144
Fairfield 138
Redwood City 120
Houston 100
Singapore 97
Torino 87
Dublin 84
Woodbridge 82
Wilmington 76
Ashburn 72
Vienna 58
Nyköping 52
Villeurbanne 47
Seattle 46
Santa Clara 44
Dearborn 41
Pisa 40
Jakarta 35
Cambridge 34
Princeton 29
Medford 28
Shanghai 28
Warsaw 28
Guangzhou 26
Columbus 25
Jacksonville 19
Fremont 18
Tariceni 18
Cape Town 17
Lima 17
Ottawa 17
Boston 16
Nanjing 16
Brussels 14
Chicago 14
Milan 14
Dong Ket 13
Turin 13
Hangzhou 12
Hanoi 11
New York 11
Seoul 11
Taipei 11
Boardman 10
New Delhi 10
Paris 10
Toronto 10
Washington 10
Bamako 9
Fuzhou 9
Martin 9
Moscow 9
Omaha 9
San Diego 9
Tianjin 9
Bangkok 8
Bogotá 8
Helsinki 8
Kunming 8
Mumbai 8
Bangalore 7
Banjul 7
Brasília 7
Buffalo 7
Central District 7
Gurgaon 7
Los Angeles 7
Mexico 7
Phoenix 7
Saint Louis 7
San Francisco 7
Santa Gertrudes 7
Bengaluru 6
Brescia 6
Budapest 6
Chengdu 6
Delhi 6
Duncan 6
Madrid 6
Munro 6
Palo Alto 6
São Paulo 6
Bergamo 5
Buenos Aires 5
Chennai 5
Memphis 5
Minneapolis 5
Padova 5
Para 5
Ribeirão Preto 5
Rome 5
Silver Spring 5
Toulouse 5
Vicenza 5
Wynberg 5
Xian 5
Zhengzhou 5
Abu Dhabi 4
Totale 2.719
Salva come PNG Salva come JPEG
Nome #
Pharmacokinetics and pharmacogenetics of anti-tubercular drugs: a tool for treatment optimization? 807
TB and COVID-19 co-infection: Rationale and aims of a global study 429
Elvitegravir/Cobicistat/Tenofovir/Emtricitabine Penetration in the Cerebrospinal Fluid of Three HIV-Positive Patients 352
Effect of SNPs in human ABCB1 on daptomycin pharmacokinetics in Caucasian patients. 339
High interpatient variability of raltegravir CSF concentrations in HIV-positive patients: a pharmacogenetic analysis. 326
A UPLC-MS-MS method for the simultaneous quantification of first-line antituberculars in plasma and in PBMCs 312
HIV-1 Very Low Level Viremia is Associated with Virological Failure in HAART-treated Patients 295
Cerebrospinal fluid viral load and neopterin in HIV-positive patients with undetectable viraemia 192
The Influence of Pharmacogenetic Variants in HIV/Tuberculosis Co-infected Patients in Uganda in the SOUTH Study 178
Anidulafungin versus fluconazole: clinical focus on IDSA and ESCMID guidelines. 175
Molecular epidemiology of methicillin-resistant S. aureus in the ICU setting. 173
Epidemiology of bloodstream infections in patients with acute myeloid leukemia undergoing levofloxacin prophylaxis 158
Tenofovir Plasma Concentrations According to Companion Drugs: a Cross-sectional Study in HIV-positive Patients with Normal Renal Function. 151
Role of vitamin D pathway gene polymorphisms on rifampicin plasma and intracellular pharmacokinetics 137
Ethambutol plasma and intracellular pharmacokinetics: A pharmacogenetic study 116
Undetectable antimicrobial plasma concentrations in an HIV-positive patient with protein-losing enteropathy and chylothorax during Mycobacterium genavense and Leishmania abdominal infections 116
Wound botulism after traumatic open fracture in Italy 109
Erratum: A probable drug-to-drug interaction between voriconazole and haloperidol in a slow metabolizer of CYP2C19 patient 103
Dried Plasma/Blood Spots for Monitoring Antiretroviral Treatment Efficacy and Pharmacokinetics: a Cross-sectional Study in Rural Burundi. 97
Level of HIV Viremia Below 50 copies/ml Predicts Virologic Rebound in HAART-treated Patients 79
Early low-molecular-weight heparin administration is associated with shorter time to SARS-CoV-2 swab negativity 75
Pharmacokinetics of first-line antitubercular drugs in plasma and PBMCs 69
Economic impact of antifungal treatment in IFD by Candida species: Anidulafungin administration as a cost-effective alternative for critical care patients 64
A probable drug-to-drug interaction between voriconazole and haloperidol in a slow metabolizer of CYP2C19 62
Risk factors for mortality in patients with Staphylococcus aureus bloodstream infection 60
Rifampicin and Isoniazid Maximal Concentrations are Below Efficacy-associated Thresholds in the Majority of Patients: Time to Increase the Doses? 49
The Effect of Rifampicin on Darunavir, Ritonavir, and Dolutegravir Exposure within Peripheral Blood Mononuclear Cells: a Dose Escalation Study 46
Low antituberculosis drug concentrations in HIV-tuberculosis-coinfected adults with low body weight: Is it time to update dosing guidelines? 38
Personalization Of Antitubercular Treatment: Evaluation Of Pharmacological Determinants Of Treatment Response 9
Totale 5.116
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.696
article - articoli 0
book - libri 0
conference - conferenze 248
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.944
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020598 0 0 0 0 78 137 74 69 47 66 50 77
2020/2021560 47 44 27 41 47 52 27 28 47 40 50 110
2021/20221.117 81 69 108 130 91 103 90 84 109 38 135 79
2022/2023633 61 66 14 57 63 138 26 48 67 28 35 30
2023/2024363 37 46 21 24 39 43 27 31 3 28 30 34
2024/2025282 14 30 46 77 115 0 0 0 0 0 0 0
Totale 5.116